MODERN EDUCATION AND DEVELOPMENT
Выпуск журнала №-28
Часть–2_Июнь –2025
351
MORPHOLOGICAL AND VASCULAR ADAPTATIONS IN THE LIVER
DURING NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD): A
STEREOLOGICAL AND IMMUNOHISTOCHEMICAL INVESTIGATION
Assistant of the Department of Anatomy and Clinical Anatomy,
Bukhara State Medical Institute named after Abu Ali ibn Sina
Davronov U.T.
Abstract: Non-alcoholic fatty liver disease (NAFLD) encompasses a spectrum
of hepatic disorders, ranging from simple steatosis to non-alcoholic steatohepatitis
(NASH), which can progress to fibrosis, cirrhosis, and hepatocellular carcinoma.
This study investigates the morphological and vascular adaptations in liver tissue
associated with NAFLD using stereological techniques and immunohistochemical
analysis. Liver biopsies from 40 patients with varying stages of NAFLD were
analyzed and compared to healthy controls. Stereological measurements quantified
volumetric and numerical changes in hepatocytes, lipid vacuoles, and fibrotic tissue,
while immunohistochemistry identified expression levels of CD34, α-SMA, and
VEGF. Findings reveal progressive structural disorganization, sinusoidal
capillarization, and increased fibrosis as disease severity increases. These results
highlight the importance of microarchitectural and vascular assessment in NAFLD
diagnosis and treatment monitoring.
1.1 Epidemiology and Risk Factors
NAFLD affects approximately 25% of the global population and is
particularly prevalent in Western countries. Its incidence is rising in parallel with the
obesity epidemic. Risk factors include insulin resistance, dyslipidemia, hypertension,
and sedentary lifestyle. NAFLD can occur in both adults and children and is
increasingly recognized as a hepatic manifestation of metabolic syndrome. Genetic
predisposition also plays a role, with variants in PNPLA3 and TM6SF2 genes
associated with increased disease susceptibility.
MODERN EDUCATION AND DEVELOPMENT
Выпуск журнала №-28
Часть–2_Июнь –2025
352
3.5 Capillarization and Neoangiogenesis
The immunohistochemical staining for CD34 revealed widespread sinusoidal
capillarization, especially in the pericentral and midzonal regions in NASH and
fibrotic livers. This is indicative of vascular remodeling which is a key feature in the
transition from simple steatosis to NASH. VEGF was predominantly expressed in
hepatocytes and endothelial cells adjacent to fibrotic bands, highlighting the role of
neoangiogenesis in fibrotic progression. This pattern of expression suggests a
paracrine loop where hypoxia-induced VEGF secretion promotes aberrant vascular
development.
4.1 Clinical Implications
The findings of this study are clinically significant in identifying
morphological biomarkers that may precede clinical symptoms of advanced NAFLD.
Understanding the interplay between hepatocellular damage, vascular changes, and
fibrosis can improve early detection strategies. These markers, if validated in larger
cohorts, may be incorporated into diagnostic algorithms alongside imaging and
serological indicators.
4.2 Future Directions
Future research should focus on longitudinal studies to monitor dynamic
changes in hepatic microarchitecture and correlate these with clinical outcomes.
Emerging technologies such as AI-assisted image segmentation, spatial
transcriptomics, and 3D tissue reconstruction could refine morphological
assessments. Moreover, therapeutic trials should consider evaluating the reversal of
vascular and fibrotic alterations as endpoints in NAFLD treatment efficacy.
1.2 Pathophysiology of NAFLD
The pathogenesis of NAFLD is multifactorial and involves a complex
interplay of metabolic, genetic, and environmental factors. The widely accepted
'multiple-hit' hypothesis suggests that insulin resistance, oxidative stress, lipid
peroxidation, and inflammatory cytokines contribute to hepatic injury. The initial
accumulation of triglycerides within hepatocytes (steatosis) sensitizes liver tissue to
subsequent insults such as mitochondrial dysfunction, endoplasmic reticulum stress,
MODERN EDUCATION AND DEVELOPMENT
Выпуск журнала №-28
Часть–2_Июнь –2025
353
and activation of resident immune cells. These processes culminate in hepatocellular
ballooning, inflammation, and eventually fibrotic remodeling.
2.6 Ethical Considerations
All procedures involving human participants were performed in accordance
with the ethical standards of the institutional and national research committees.
Written informed consent was obtained from all participants before inclusion in the
study. Sample handling and analysis were conducted following the Declaration of
Helsinki principles. Data anonymity and patient confidentiality were strictly
maintained throughout the study period.
3.6 Summary of Quantitative Morphometric Data
Table 1 below summarizes the volume densities and immunohistochemical
scores for key hepatic components across the different NAFLD stages and the control
group. Data include volume density of hepatocytes (Vv[Hep]), lipid vacuoles
(Vv[Lip]), sinusoids (Vv[Sin]), fibrosis (Vv[Fib]), and IHC scores for CD34, α-SMA,
and VEGF.
4.3 Role of Hepatic Stellate Cells
Hepatic stellate cells (HSCs) are central to the fibrogenic response in NAFLD.
Under quiescent conditions, HSCs store vitamin A and reside in the space of Disse.
Upon activation by inflammatory cytokines (e.g., TGF-β, TNF-α) and oxidative
stress, they transdifferentiate into myofibroblast-like cells expressing α-SMA and
secrete large amounts of extracellular matrix proteins. This leads to sinusoidal
constriction, altered perfusion, and progressive fibrosis. The degree of α-SMA
positivity in this study directly correlated with fibrosis score, confirming HSC
activation as a pathological hallmark.
5.1 Recommendations for Clinical Practice
Based on our findings, integrating stereological and immunohistochemical
profiling into clinical workflows may enhance the early detection of NASH. Non-
invasive imaging methods, such as MRI elastography and contrast-enhanced
ultrasound, could be calibrated using histological data to improve diagnostic
MODERN EDUCATION AND DEVELOPMENT
Выпуск журнала №-28
Часть–2_Июнь –2025
354
precision. Routine monitoring of angiogenic and fibrogenic biomarkers (e.g., VEGF,
α-SMA) may also provide prognostic value and guide treatment strategies.
REFERENCES
1.
1. Angulo, P. (2002). Nonalcoholic fatty liver disease. New England Journal of
Medicine, 346(16), 1221–1231.
2.
2. Wanless, I. R., et al. (1995). Hepatic sinusoidal fibrosis in nonalcoholic
steatohepatitis. Hepatology, 21(2), 333–339.
3.
3. Tiniakos, D. G., et al. (2010). Histological evaluation of NAFLD: Current
concepts and challenges. Histopathology, 56(5), 521–536.
4.
4. Schaffner, F., & Thaler, H. (1986). Nonalcoholic fatty liver disease. Progress in
Liver Diseases, 8, 283–298.
5.
5. Bataller, R., & Brenner, D. A. (2005). Liver fibrosis. Journal of Clinical
Investigation, 115(2), 209–218.
6.
6. Chalasani, N., et al. (2018). The diagnosis and management of nonalcoholic
fatty liver disease: Practice guidance from the AASLD. Hepatology, 67(1), 328–357.
7.
7. Marra, F., & Lotersztajn, S. (2013). Pathophysiology of NASH: perspectives
for a targeted treatment. Current Pharmaceutical Design, 19(29), 5250–5269.
8.
8. Buzzetti, E., Pinzani, M., & Tsochatzis, E. A. (2016). The multiple-hit
pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism, 65(8),
1038–1048.
9.
9. Tilg, H., & Moschen, A. R. (2010). Evolution of inflammation in nonalcoholic
fatty liver disease: The multiple parallel hits hypothesis. Hepatology, 52(5), 1836–
1846.
10.
10. Sanyal, A. J., et al. (2001). Nonalcoholic steatohepatitis: association of insulin
resistance and mitochondrial abnormalities. Gastroenterology, 120(5), 1183–1192.
